26.13
0.25 (0.97%)
0.25 (0.97%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
CHART Trader
Monthly Subscription
for only
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
Small Cap Basic
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Pliant Therapeutics Inc | PLRX | NASDAQ | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded ![]() |
|
---|---|---|---|---|
0.25 | 0.97% | 26.13 | 20:00:00 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
25.72 | 24.40 | 27.44 | 26.13 | 25.88 |
Bid Price | Ask Price | Spread | News | |
---|---|---|---|---|
19.50 | 35.00 | 15.50 | - | - |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,492 | 72,073 | $ 25.74 | $ 1,855,263 | 92,784 | 19.425 - 35.63 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:01:07 | 27 | $ 26.13 | USD |
Pliant Therapeutics Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 927.09M | 35.48M | 26.19M | $ 57.05M | $ -34.37M | -0.04 | 38.10 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | 0.00% | -11.50k | 1.50% |
Pliant Therapeutics News
Date | Time | Source | News Article |
---|---|---|---|
1/13/2021 | 18:15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
1/13/2021 | 17:09 | Edgar (US Regulatory) | Current Report Filing (8-k) |
1/12/2021 | 08:00 | GlobeNewswire Inc. | Pliant Therapeutics Announces Appointment of David Pyott to.. |
1/04/2021 | 08:00 | GlobeNewswire Inc. | Pliant Therapeutics Announces Appointment of Gregory P... |
12/21/2020 | 06:07 | Edgar (US Regulatory) | Current Report Filing (8-k) |
11/19/2020 | 08:00 | PR Newswire (US) | Pliant Therapeutics To Participate In The Piper Sandler 32nd.. |
11/10/2020 | 16:24 | Edgar (US Regulatory) | Quarterly Report (10-q) |
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PLRX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 27.91 | 28.22 | 24.40 | 27.26 | 36,532 | -1.78 | -6.38% |
1 Month | 27.12 | 28.22 | 22.53 | 25.66 | 77,216 | -0.99 | -3.65% |
3 Months | 23.08 | 33.00 | 19.425 | 26.18 | 73,241 | 3.05 | 13.21% |
6 Months | 23.00 | 33.00 | 19.425 | 25.30 | 93,517 | 3.13 | 13.61% |
1 Year | 22.50 | 35.63 | 19.425 | 25.20 | 112,728 | 3.63 | 16.13% |
3 Years | 22.50 | 35.63 | 19.425 | 25.20 | 112,728 | 3.63 | 16.13% |
5 Years | 22.50 | 35.63 | 19.425 | 25.20 | 112,728 | 3.63 | 16.13% |
Pliant Therapeutics Description
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. |